GOLDEN, Colo. and CAIRO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- PharmaJet®, a company that strives to improve the performance and outcomes of injectables with its enabling needle-free injection technology, ...
PharmaJet® Tropis® Needle-Free Injection System Selected for Polio Immunization Campaign in Pakistan
The PharmaJet Tropis Intradermal (ID) Needle-free System will be used exclusively to deliver vaccine to 1.8 million children in upcoming campaign. To date, 12+ million pediatric injections have been ...
In Cuba, the routine immunization (RI) schedule for polio consists of two doses of fIPV administered at 4 and 8 months of age administered intradermally with N/S. However, ID administration with N/S ...
GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, a company who has developed and commercialized an intradermal needle-free platform to more effectively administer drugs and biologics, today announced that ...
A new nanoparticle vaccine developed by MIT researchers could assist efforts to eradicate polio worldwide. The vaccine, which delivers multiple doses in just one injection, could make it easier to ...
The introduction of Tropis into immunization programs supports Egypt’s "1000 Golden Days" initiative which was launched to support the health and development of families during the critical period ...
Riad Armanious, CEO of EVA Pharma and Wouter Latour, CEO of PharmaJet shake hands after signing the distribution agreement to provide PharmaJet Needle-free Injection Systems for routine polio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback